Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

NCT06273852 is registered in ClinicalTrials.gov with Pure Biologics S.A. as lead sponsor.

NCT NCT06273852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Lead sponsor
Pure Biologics S.A.
Phase
Phase 1
Overall status
Completed
Start date
April 29, 2024
Completion date
March 31, 2025
Enrollment
8 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, soft tissue sarcoma adult, triple negative breast cancer